The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
The emerging safety profile of JAK inhibitors in rheumatic disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E., McNaughton, C., Osani, M., Shmerling, R. H., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39480 · Cited by 2,777
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
JAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10524 · Cited by 1,214
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
O'Shea, J. J., & Plenge, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.014 · Cited by 1,138
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E., McNaughton, C., Osani, M., Shmerling, R. H., et al. (2016) · Arthritis Care & Research · doi:10.1002/acr.22783 · Cited by 1,107
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,037
JAKs and STATs in immunity, immunodeficiency, and cancer
O'Shea, J. J., Holland, S. M., & Staudt, L. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1202117 · Cited by 927
Ruxolitinib versus standard therapy for the treatment of polycythemia vera
Vannucchi, A. M., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Mesa, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409002 · Cited by 891
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
Cytokine Signaling Modules in Inflammatory Responses
O'Shea, J. J., & Murray, P. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.002 · Cited by 818
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
Karch, D. L., Dahlberg, L. L., & Patel, N. (2010) · PsycEXTRA Dataset · doi:10.1037/e587232010-001 · Cited by 745
Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
Baricitinib in Patients with Refractory Rheumatoid Arthritis
Genovese, M. C., Kremer, J., Zamani, O., Ludivico, C., Krogulec, M., Xie, L., Beattie, S. D., Koch, A. E., Cardillo, T. E., Rooney, T. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507247 · Cited by 627
Clark, J. D., Flanagan, M. E., & Telliez, J.-B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401490p · Cited by 601
Burmester, G. R., Panaccione, R., Gordon, K. B., McIlraith, M. J., & Lacerda, A. P. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201244 · Cited by 591
Khamashta, M., Merrill, J. T., Werth, V. P., Furie, R., Kalunian, K., Illei, G. G., Drappa, J., Wang, L., & Greth, W. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208562 · Cited by 503
Dougados, M., van der Heijde, D., Chen, Y.-C., Greenwald, M., Drescher, E., Liu, J., Beattie, S., Witt, S., de la Torre, I., Gaich, C., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210094 · Cited by 404
van Vollenhoven, R. F., Emery, P., Bingham, C. O., Keystone, E. C., Fleischmann, R. M., Furst, D. E., Tyson, N., Collinson, N., & Lehane, P. B. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201956 · Cited by 390
Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
Winthrop, K. L., Yamanaka, H., Valdez, H., Mortensen, E., Chew, R., Krishnaswami, S., Kawabata, T., & Riese, R. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38745 · Cited by 353
Self-citationA new modality for immunosuppression: targeting the JAK/STAT pathway
O'Shea, J. J., Pesu, M., Borie, D. C., & Changelian, P. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1441 · Cited by 303
Askling, J., Fahrbach, K., Nordstrom, B., Ross, S., Schmid, C. H., & Symmons, D. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2046 · Cited by 301
Wollenhaupt, J., Silverfield, J., Lee, E. B., Curtis, J. R., Wood, S. P., Soma, K., Nduaka, C. I., Benda, B., Gruben, D., Nakamura, H., et al. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130683 · Cited by 301
Long-term Persistence of Zoster Vaccine Efficacy
Morrison, V. A., Johnson, G. R., Schmader, K. E., Levin, M. J., Zhang, J. H., Looney, D. J., Betts, R., Gelb, L., Guatelli, J. C., Harbecke, R., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu918 · Cited by 296
Curtis, J. R., Xie, F., Yun, H., Bernatsky, S., & Winthrop, K. L. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209131 · Cited by 285
Self-citationZhang, J., Xie, F., Delzell, E., Chen, L., Winthrop, K. L., Lewis, J. D., Saag, K. G., Baddley, J. W., & Curtis, J. R. (2012) · JAMA · doi:10.1001/jama.2012.7304 · Cited by 283
Self-citationSmitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A., & Chan, K. A. (2007) · Arthritis Care & Research · doi:10.1002/art.23112 · Cited by 281
Winthrop, K. L., Park, S.-H., Gul, A., Cardiel, M. H., Gomez-Reino, J. J., Tanaka, Y., Kwok, K., Lukic, T., Mortensen, E., Ponce de Leon, D., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207319 · Cited by 249
Self-citationWesthovens, R., Taylor, P. C., Alten, R., Pavlova, D., Enríquez-Sosa, F., Mazur, M., Greenwald, M., Van der Aa, A., Vanhoutte, F., Tasset, C., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210104 · Cited by 236
Kavanaugh, A., Kremer, J., Ponce, L., Cseuz, R., Reshetko, O. V., Stanislavchuk, M., Greenwald, M., Van der Aa, A., Vanhoutte, F., Tasset, C., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210105 · Cited by 229
Winthrop, K. L., Baddley, J. W., Chen, L., Liu, L., Grijalva, C. G., Delzell, E., Beukelman, T., Patkar, N. M., Xie, F., Saag, K. G., et al. (2013) · JAMA · doi:10.1001/jama.2013.1099 · Cited by 223
Self-citationGenovese, M. C., Smolen, J. S., Weinblatt, M. E., Burmester, G. R., Meerwein, S., Camp, H. S., Wang, L., Othman, A. A., Khan, N., Pangan, A. L., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39808 · Cited by 200
A partial form of recessive STAT1 deficiency in humans
Chapgier, A., Kong, X.-F., Boisson-Dupuis, S., Jouanguy, E., Averbuch, D., Feinberg, J., Zhang, S.-Y., Bustamante, J., Vogt, G., Lejeune, J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37083 · Cited by 188
Kremer, J. M., Emery, P., Camp, H. S., Friedman, A., Wang, L., Othman, A. A., Khan, N., Pangan, A. L., Jungerwirth, S., & Keystone, E. C. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39801 · Cited by 182
Update on recommendations for use of herpes zoster vaccine.
Hales, C. M., Harpaz, R., Ortega‐Sanchez, I. R., & Bialek, S. R. (2014) · PubMed Central · Cited by 179
Cohen, S., Radominski, S. C., Gomez‐Reino, J. J., Wang, L., Krishnaswami, S., Wood, S. P., Soma, K., Nduaka, C. I., Kwok, K., Valdez, H., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38779 · Cited by 173
Curtis, J. R., Lee, E. B., Kaplan, I. V., Kwok, K., Geier, J., Benda, B., Soma, K., Wang, L., & Riese, R. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205847 · Cited by 170
Functional Correlations of Pathogenesis-Driven Gene Expression Signatures in Tuberculosis
Maertzdorf, J., Ota, M., Repsilber, D., Mollenkopf, H. J., Weiner, J., Hill, P. C., & Kaufmann, S. H. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026938 · Cited by 167
Xie, F., Yun, H., Bernatsky, S., & Curtis, J. R. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39761 · Cited by 161
Winthrop, K. L., Novosad, S., Baddley, J. W., Calabrese, L. H., Chiller, T. M., Polgreen, P. M., Bartalesi, F., Lipman, M. C. I., Mariette, X., Lortholary, O., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207841 · Cited by 152
Self-citationTakeuchi, T., Tanaka, Y., Iwasaki, M., Ishikura, H., Saeki, S., & Kaneko, Y. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208279 · Cited by 152
Genovese, M., Rubbert-Roth, A., Smolen, J., Kremer, J., Khraishi, M., Gómez-Reino, J., Sebba, A., Pilson, R., Williams, S., & van Vollenhoven, R. (2013) · Journal of Rheumatology · doi:10.3899/jrheum.120687 · Cited by 139
Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
Wathes, R., Moule, S., & Milojković, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1302135 · Cited by 137
Schmajuk, G., Trivedi, A. N., Solomon, D. H., Yelin, E. H., Trupin, L. S., Chakravarty, E. F., & Yazdany, J. (2011) · JAMA · doi:10.1001/jama.2011.67 · Cited by 132
Genovese, M. C., van Vollenhoven, R., Pacheco‐Tena, C., Zhang, Y., & Kinnman, N. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39473 · Cited by 130
Simon, T. A., Smitten, A. L., Franklin, J. P., Askling, J., Lacaille, D. V., Wolfe, F., Hochberg, M. C., Qi, K., & Suissa, S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.097527 · Cited by 129
Back to the future: oral targeted therapy for RA and other autoimmune diseases
O'Shea, J. J., Laurence, A., & McInnes, I. B. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.7 · Cited by 115
Fleischmann, R., DAMJANOV, N. S., Kivitz, A., Legedza, A. K., Hoock, T. C., & Kinnman, N. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38949 · Cited by 114
Thoma, G., Nuninger, F., Falchetto, R. A., Hermes, E., Tavares, G., Vangrevelinghe, E., & Zerwes, H. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101157q · Cited by 100
Kremer, J. M., Kivitz, A., Campos, J. A. S., Nasonov, E. L., Tony, H., Lee, S.-K., Vlahos, B. L., Hammond, C., Bukowski, J. F., Li, H., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0612-7 · Cited by 55
Smolen, J. S., Kay, J., Landewé, R., Matteson, E. L., GAYLIS, N. B., Wollenhaupt, J., Murphy, F. T., Zhou, Y., Hsia, E. C., & Doyle, M. K. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200956 · Cited by 55
Winthrop, K. L., & Fürst, D. E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.133843 · Cited by 35
Self-citationEfficacy and safety of ruxolitinib in Asian patients with myelofibrosis
Jung, C. W., Shih, L., Xiao, Z., Jie, J., Hou, H., Du, X., Wang, M.-C., Park, S., Eom, K., Oritani, K., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.969260 · Cited by 34
Dougados, M., van der Heijde, D. M. F. M., Chen, Y., Greenwald, M., Drescher, E., Liu, J., Beattie, S. D., de la Torre, I., Rooney, T. P., Schlichting, D. E., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-eular.6539 · Cited by 31
Genovese, M. C., Kremer, J. M., Zamani, O., Ludivico, C. L., Krogulec, M., Xie, L., Beattie, S. D., Koch, A. E., Cardillo, T. E., Rooney, T. P., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-eular.1427 · Cited by 27
Varicella Zoster Virus DNA at Inoculation Sites and in Saliva After Zostavax Immunization
Pierson, D. L., Mehta, S. K., Gilden, D., Cohrs, R. J., Nagel, M. A., Schmid, D. S., & Tyring, S. K. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir139 · Cited by 24
van Vollenhoven, R., Tanaka, Y., Lamba, M., Collinge, M., Hendrikx, T. K., Hirose, T., Toyoizumi, S., Hazra, A., & Krishnaswami, S. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-eular.3674 · Cited by 13
Cited by
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Smolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
Dashraath, P., Wong, J. L. J., Lim, M. X. K., Lim, L. M., Li, S., Biswas, A., Choolani, M., Mattar, C., & Su, L. L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.021 · Cited by 1,432
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Metadata
- Authors
- Winthrop, K. L.
- Venue
- Nature Reviews Rheumatology
- Published
- 2017-03-02
- Volume
- 13
- Issue
- 4
- Pages
- 234-243
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2593565645
- Cited by
- 590
- References
- 62
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.